Financings Material −

iFabric Corp. Announces $20 Million Bought Deal Treasury and Secondary Offering

iFabric’s $20M bought deal at discount clouds record quarter, as founders sell near all‑time highs.

By The Northwire Desk — AI Analysis May 13, 2026 · 16:06 IFA · 4.13 IFABRIC CORP. J

Executive Summary

On May 13, 2026, iFabric announced a bought‑deal financing with Beacon Securities for $20 million.
The offering comprises a $15 million treasury issue (4,055,000 new common shares at $3.70) and a $5 million secondary issue (1,352,000 shares from selling shareholders Hylton Karon and Susan Karon at the same $3.70).
Underwriters have a 15% overallotment option, potentially adding another $3 million.
Use of treasury proceeds: product development, sales & marketing expansion, working capital.
After the deal, the Karons will hold 17,836,850 shares, or ~51.9% of the company.
Closing expected on or about June 4, 2026.

Material Impact

The offering comes just one day after iFabric reported record Q1 2026 revenue ($27.5 M, up 288%) and earnings, which had already driven the stock to $4.13.
Pricing at $3.70 represents a 10.4% discount to the last close, diluting existing shareholders and signaling potential capital pressure despite the record results.
The secondary sale by the CEO and his spouse for $5 million is a material negative signal – insiders are taking profits at the same time the company asks public investors for fresh capital.
The fact that the raise is needed so soon after reporting over $27 million in revenue raises concerns about working‑capital intensity and cash‑flow generation.
While the treasury component funds legitimate growth (product development, marketing), the discount and insider selling overshadow the positive momentum from the record quarter.
Overall, the news is genuinely unexpected and market‑moving in a negative direction; a financing was not explicitly telegraphed in the recent earnings call, and the secondary element adds a layer of distrust.

IFA · Price

Company Overview

iFabric Corp. operates through two divisions: Intelligent Fabric Technologies (North America) Inc. (IFTNA) and Coconut Grove/Intimate Apparel.
Flagship technology: PROTX2® antimicrobial treatment and ecoPEL™ water‑repellent finish, backed by a peer‑reviewed clinical trial in the Journal of Hospital Infection (2025).
Flagship commercial project: clinically‑proven medical scrubs (Frontline™, Doctor’s Choice®) sold through major retailers like Walmart (expansion to 1,000 additional stores in Q1 2026) and Costco Canada. Also the Roots® footwear program and the nascent Nudish™ intimate apparel brand (replaced Maidenform® license).
The company is expanding into new categories (bedding via The Lad Collective, footwear) and exploring hospital direct sales.

More from IFABRIC CORP. J